Literature DB >> 8905441

MDMA induced hyperthermia: report of a fatality and review of current therapy.

K J Dar1, M E McBrien.   

Abstract

Ingestion of 3,4-methylene dioxymethamphetamine (MDMA), commonly known as "Ecstasy", can produce toxicity that is characterised by hyperthermia, coagulopathy, rhabdomyolysis and renal failure. We report a fatality associated with MDMA ingestion and briefly review the current literature on MDMA-induced hyperthermia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8905441     DOI: 10.1007/bf02044131

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  13 in total

1.  Another death from Ecstacy.

Authors:  N T Campkin; U M Davies
Journal:  J R Soc Med       Date:  1992-01       Impact factor: 5.344

Review 2.  The serotonin syndrome.

Authors:  H Sternbach
Journal:  Am J Psychiatry       Date:  1991-06       Impact factor: 18.112

Review 3.  Myocardial contraction bands revisited.

Authors:  S B Karch; M E Billingham
Journal:  Hum Pathol       Date:  1986-01       Impact factor: 3.466

Review 4.  Motor effects of serotonin in the central nervous system.

Authors:  S C Gerson; R J Baldessarini
Journal:  Life Sci       Date:  1980-10-20       Impact factor: 5.037

5.  Multiple severe complications from recreational ingestion of MDMA ('Ecstasy')

Authors:  C Brown; J Osterloh
Journal:  JAMA       Date:  1987-08-14       Impact factor: 56.272

6.  Survival following 'Ecstasy' ingestion with a peak temperature of 42 degrees C.

Authors:  A S Logan; B Stickle; N O'Keefe; H Hewitson
Journal:  Anaesthesia       Date:  1993-11       Impact factor: 6.955

7.  Ecstasy intoxication: appreciation of complications and the role of dantrolene.

Authors:  C Webb; V Williams
Journal:  Anaesthesia       Date:  1993-06       Impact factor: 6.955

8.  Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy")

Authors:  J A Henry; K J Jeffreys; S Dawling
Journal:  Lancet       Date:  1992-08-15       Impact factor: 79.321

9.  Methylenedioxymethamphetamine-induced hyperthermia and neurotoxicity are independently mediated by 5-HT2 receptors.

Authors:  C J Schmidt; C K Black; G M Abbate; V L Taylor
Journal:  Brain Res       Date:  1990-10-08       Impact factor: 3.252

10.  Ecstasy, 3-4 methylenedioxymethamphetamine (MDMA), a fatality associated with coagulopathy and hyperthermia.

Authors:  I S Chadwick; P D Curry; A Linsley; A J Freemont; B Doran
Journal:  J R Soc Med       Date:  1991-06       Impact factor: 18.000

View more
  13 in total

Review 1.  Street drug abuse leading to critical illness.

Authors:  Babak Mokhlesi; Prasad S Garimella; Aaron Joffe; Valerie Velho
Journal:  Intensive Care Med       Date:  2004-03-04       Impact factor: 17.440

2.  Death following recreational use of designer drug "bath salts" containing 3,4-Methylenedioxypyrovalerone (MDPV).

Authors:  Brittany L Murray; Christine M Murphy; Michael C Beuhler
Journal:  J Med Toxicol       Date:  2012-03

Review 3.  The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs.

Authors:  H Kalant
Journal:  CMAJ       Date:  2001-10-02       Impact factor: 8.262

4.  Role of the serotonin 5-HT2A receptor in the hyperlocomotive and hyperthermic effects of (+)-3,4-methylenedioxymethamphetamine.

Authors:  David V Herin; Shijing Liu; Thomas Ullrich; Kenner C Rice; Kathryn A Cunningham
Journal:  Psychopharmacology (Berl)       Date:  2004-10-23       Impact factor: 4.530

5.  "Ecstasy" associated deaths: what is a fatal concentration ? Analysis of a case series.

Authors:  C M Milroy
Journal:  Forensic Sci Med Pathol       Date:  2011-01-25       Impact factor: 2.007

6.  Thermoregulatory effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans.

Authors:  Robert R Freedman; Chris-Ellyn Johanson; Manuel E Tancer
Journal:  Psychopharmacology (Berl)       Date:  2005-11-09       Impact factor: 4.530

Review 7.  The role of the sympathetic nervous system and uncoupling proteins in the thermogenesis induced by 3,4-methylenedioxymethamphetamine.

Authors:  Edward M Mills; Daniel E Rusyniak; Jon E Sprague
Journal:  J Mol Med (Berl)       Date:  2004-11-10       Impact factor: 4.599

8.  Changes in ambient temperature differentially alter the thermoregulatory, cardiac and locomotor stimulant effects of 4-methylmethcathinone (mephedrone).

Authors:  M L Miller; K M Creehan; D Angrish; D J Barlow; K L Houseknecht; T J Dickerson; M A Taffe
Journal:  Drug Alcohol Depend       Date:  2012-07-23       Impact factor: 4.492

9.  Attenuation of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced rhabdomyolysis with alpha1- plus beta3-adrenoreceptor antagonists.

Authors:  Jon E Sprague; Robert E Brutcher; Edward M Mills; David Caden; Daniel E Rusyniak
Journal:  Br J Pharmacol       Date:  2004-05-24       Impact factor: 8.739

10.  Small changes in ambient temperature cause large changes in 3,4-methylenedioxymethamphetamine (MDMA)-induced serotonin neurotoxicity and core body temperature in the rat.

Authors:  J E Malberg; L S Seiden
Journal:  J Neurosci       Date:  1998-07-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.